Mostly based on health care records and cancer registries; a few studies used self-reported dataHormone receptor subtypes were defined based on ER, PR, HER2, and grade of the tumor. Methods to assess these tumor markers differed across individual studies and included clinical/pathology records and IHC of whole tumor sections of tissue microarrays. This evidence concerns the gene PGR and neoplasm.